{"brief_title": "Alternate-Day Buprenorphine Administration. Phase VII - 8", "brief_summary": "The purpose of this study is to determine if four times a subjects daily maintenance dose will hold for 96 hours without changes in agonist and antagonist effects under open dosing conditions.", "condition": ["Opioid-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Buprenorphine"], "criteria": "Please contact site for information.", "gender": "All", "minimum_age": "21 Years", "maximum_age": "48 Years", "healthy_volunteers": "No", "mesh_term": ["Opioid-Related Disorders", "Buprenorphine"], "id": "NCT00000226"}